Top

International Journal of Clinical Pharmacy

Published in:

01-04-2009 | Research Article

Drug-related problems identified in medication reviews by Australian pharmacists

Authors: Andrew C. Stafford, Peter C. Tenni, Gregory M. Peterson, Shane L. Jackson, Anne Hejlesen, Christine Villesen, Mette Rasmussen

Published in: International Journal of Clinical Pharmacy | Issue 2/2009

Abstract

Objective In Australia, accredited pharmacists perform medication reviews for patients to identify and resolve drug-related problems. We analysed the drug-related problems identified in reviews for both home-dwelling and residential care-facility patients. The objective of this study was to examine the number and nature of the drug-related problems identified and investigate differences between each type of review. Setting Australian patients living at home or in residential care-facilities. Method We collected a nation-wide sample of medication reviews conducted between 1998 and 2005. These reviews had been self-selected by pharmacists and submitted as part of the reaccreditation process to the primary body responsible for accrediting Australian pharmacists to perform medication reviews. The drug-related problems identified in each review were classified by type and drugs involved. Main outcome measure The number and nature of drug-related problems identified in pharmacist-conducted medication reviews. Results There were 1,038 drug-related problems identified in 234 medication reviews (mean 4.6 (±2.2) problems per review). The number of problems was higher (4.9 ± 2.0 vs. 3.9 ± 2.2; P < 0.001) in reviews for home-dwelling patients compared with care-facility residents. The number of clinically-significant problems was higher (2.1 ± 1.1 vs. 1.5 ± 0.7; P < 0.001) for home-dwelling patients. Oral hypoglycaemics and analgesics/antipyretics were significantly more likely to be associated with problems in home-dwelling patients than in residential care-facility patients. Conclusion These data illustrate the prevalence of drug-related problems and the ability of pharmacists to identify these problems in the Australian models of medication review. The nature and frequency of problems varied between reviews for home-dwelling and care-facility patients. Such information may be used to better focus the training of practitioners based on the most frequently encountered health problems and the nature of common drug-related problems in the two settings.

Population Projections: Australia 2004–2101 (Reissue). Australian Bureau of Statistics. http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/73D26920772F929ECA25718C001518FB/$File/32220_2004%20to%202101reissue.pdf. Accessed 2009 Jan 27.

Farris KB, Ganther-Urmie JM, Fang G, Doucette WR, Brooks JM, Klepser DG, et al. Population-based medication reviews: a descriptive analysis of the medication issues identified in a Medicare not-for-profit prescription discount program. Ann Pharmacother. 2004;38(11):1823–9. doi:10.1345/aph.1E204.PubMedCrossRef

Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121–6. doi:10.1046/j.1365-2125.2003.01875.x.PubMedCrossRef

Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging. 2005;22(7):559–69. doi:10.2165/00002512-200522070-00002.PubMedCrossRef

Roughead EE. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract. 1999;19(1):19–22. doi:10.1046/j.1440-1762.1999.00288.x.PubMedCrossRef

Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf. 2004;13(2):83–7. doi:10.1002/pds.912.PubMedCrossRef

Christensen D, Trygstad T, Sullivan R, Garmise J, Wegner SE. A pharmacy management intervention for optimizing drug therapy for nursing home patients. Am J Geriatr Pharmacother. 2004;2(4):248–56. doi:10.1016/j.amjopharm.2004.12.002.PubMedCrossRef

Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51:257–65. doi:10.1046/j.1365-2125.2001.00347.x.PubMedCrossRef

Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomised, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648–64. doi:10.1111/j.1365-2125.2004.02220.x.PubMedCrossRef

10.

Rao D, Gilbert A, Strand LM, Cipolle RJ. Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci. 2007;29(6):647–54. doi:10.1007/s11096-007-9123-1.PubMedCrossRef

11.

Framework Document for Domiciliary Medication Management Reviews. Medication Management Implementation Steering Group. http://www.psa.org.au/site.php?id=856. Accessed 2009 Jan 27.

12.

Guidelines and Standards for the Collaborative and Pharmacist Residential Medication Management Review (RMMR) Program and Quality Use of Medicines (QUM) Services. Pharmaceutical Society of Australia. http://www.psa.org.au/site.php?id=1122. Accessed 2009 Jan 27.

13.

Burkiewicz JS, Sweeney BL. Medication reviews in senior community housing centers. Consul Pharm. 2006;21(9):715–8.

14.

Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165(1):68–74. doi:10.1001/archinte.165.1.68.PubMedCrossRef

15.

Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80. doi:10.1136/qhc.12.3.176.PubMedCrossRef

16.

Home Medicines Review (HMR). Medicare Australia. http://www.medicareaustralia.gov.au/provider/pbs/fourth-agreement/hmr.jsp. Accessed Jan 27 2009.

17.

Peterson GM, Tenni PC. Identifying, prioritising and documenting drug-related problems. Aust Pharm. 2004;23(10):706–9.

18.

van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859–67. doi:10.1345/aph.1D182.PubMedCrossRef

19.

Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care. Age Ageing. 2001;30(3):205–11. doi:10.1093/ageing/30.3.205.PubMedCrossRef

20.

Haugbolle LS, Sorensen EW. Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma—interviewing patients at home. Pharm World Sci. 2006;28(4):239–47. doi:10.1007/s11096-006-9023-9.PubMedCrossRef

21.

Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32(5):469–76. doi:10.1111/j.1365-2710.2007.00849.x.PubMedCrossRef

22.

Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36(1):58–66.

23.

Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16(6):641–51. doi:10.1002/pds.1351.PubMedCrossRef

Title: Drug-related problems identified in medication reviews by Australian pharmacists
Authors: Andrew C. Stafford
Peter C. Tenni
Gregory M. Peterson
Shane L. Jackson
Anne Hejlesen
Christine Villesen
Mette Rasmussen
Publication date: 01-04-2009
Publisher: Springer Netherlands
Published in: International Journal of Clinical Pharmacy / Issue 2/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI: https://doi.org/10.1007/s11096-009-9287-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Provision of medicines information in Australian community pharmacies

ESCP 37th European Symposium on Clinical Pharmacy, Pharmaceutical Care Models, and Therapeutic Innovations, Dubrovnik, Croatia, 21–24 October 2008

National implementation of standards of practice for non-prescription medicines in Australia

Psychosocial and behavioural determinants of the implementation of Pharmaceutical Care in Spain

Study on the use of drugs in patients with enteral feeding tubes

Availability, affordability, and prescribing pattern of medicines in Sudan

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials